Skip to main content
. 2022 May 4;11(9):1540. doi: 10.3390/cells11091540

Figure 4.

Figure 4

The role of LINC00665 in resistance to anticancer drugs. LINC00665 is involved in the drug action of gefitinib and cisplatin in non-small cell lung cancer, and the drug action of gemcitabine in cholangiocarcinoma, thereby enhancing tumor cell resistance. CCA, cholangiocarcinoma; NSCLC, non-small cell lung cancer.